Thomas E Morrison Selected Research

Alphavirus Infections

11/2021	MARCO+ lymphatic endothelial cells sequester arthritogenic alphaviruses to limit viremia and viral dissemination.
1/2021	Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus.
1/2018	Innate immune control of alphavirus infection.
12/2017	Inflammatory monocytes mediate control of acute alphavirus infection in mice.
10/2015	Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells.
10/2012	Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm.
10/2012	Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus.
10/2009	Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas E Morrison Research Topics

Disease

36	Infections 01/2021 - 01/2004
14	Virus Diseases (Viral Diseases) 01/2021 - 01/2008
12	Arthritis (Polyarthritis) 01/2020 - 01/2007
8	Alphavirus Infections 11/2021 - 10/2009
7	COVID-19 05/2022 - 01/2021
5	Inflammation (Inflammations) 10/2018 - 11/2008
4	Viremia 11/2021 - 10/2019
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2018 - 05/2007
2	Coronavirus Infections 05/2022 - 10/2018
2	Persistent Infection 01/2020 - 01/2014
2	Chronic Disease (Chronic Diseases) 01/2017 - 12/2013
2	Musculoskeletal Diseases (Musculoskeletal Disease) 11/2014 - 05/2013
2	Rheumatic Diseases (Rheumatism) 03/2014 - 05/2013
1	Vascular Diseases (Vascular Disease) 04/2021
1	Thrombotic Microangiopathies 04/2021
1	Ross River Virus Infection 01/2021
1	Arthralgia (Joint Pain) 01/2020
1	Neoplasms (Cancer) 12/2019
1	Mycoses (Diseases, Fungus) 10/2018
1	RNA Virus Infections 01/2017
1	Reoviridae Infections 01/2016
1	Vesicular Stomatitis 01/2016
1	Chikungunya Fever 01/2016
1	West Nile Fever 12/2015
1	Parkinson Disease (Parkinson's Disease) 12/2015
1	Necrosis 11/2014
1	Wounds and Injuries (Trauma) 01/2014
1	Tendinopathy (Tendonitis) 12/2013
1	Synovitis 12/2013
1	Dengue (Dengue Fever) 10/2012
1	Disease Progression 01/2012
1	Communicable Diseases (Infectious Diseases) 03/2011
1	Human Influenza (Influenza) 03/2011
1	Weight Loss (Weight Reduction) 04/2010
1	Bronchiolitis 04/2010

Drug/Important Bio-Agent (IBA)

15	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2004
8	VaccinesIBA 05/2022 - 03/2014
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2004
6	Complement System Proteins (Complement)IBA 04/2021 - 05/2007
5	RNA (Ribonucleic Acid)IBA 12/2019 - 10/2012
5	Viral RNAIBA 10/2019 - 12/2015
4	CytokinesIBA 04/2021 - 03/2011
4	Neutralizing AntibodiesIBA 01/2021 - 01/2019
3	AntibodiesIBA 01/2021 - 01/2021
3	EpitopesIBA 01/2021 - 01/2019
3	Interferon Type IIBA 01/2021 - 01/2007
3	Explosive Agents (Explosives)IBA 01/2020 - 11/2008
3	Arginine (L-Arginine)FDA Link 10/2019 - 01/2014
3	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2018 - 01/2012
3	Amino Acids FDA Link 11/2014 - 05/2013
2	ChemokinesIBA 04/2021 - 10/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 11/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 01/2019
2	Monoclonal AntibodiesIBA 12/2019 - 08/2014
2	Glycoproteins (Glycoprotein)IBA 10/2019 - 05/2013
2	Nucleic AcidsIBA 06/2017 - 01/2008
2	InterferonsIBA 10/2015 - 04/2014
2	Tyrosine (L-Tyrosine)FDA Link 05/2013 - 10/2009
2	Complement C3 (C3 Complement)IBA 03/2011 - 11/2008
2	Transcription Factors (Transcription Factor)IBA 08/2009 - 05/2004
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2021
1	AntigensIBA 10/2021
1	Immunoglobulin G (IgG)IBA 10/2021
1	Lipid NanoparticlesIBA 04/2021
1	Excipients (Suspending Agents)IBA 04/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Investigational DrugsIBA 01/2021
1	Broadly Neutralizing AntibodiesIBA 01/2021
1	OvalbuminIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Therapeutic UsesIBA 12/2019
1	Lysine (L-Lysine)FDA Link 10/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Peptide LibraryIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2018
1	LigandsIBA 01/2018
1	Capsid Proteins (Capsid Protein)IBA 06/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2017
1	Digoxin (Digitek)FDA LinkGeneric 01/2016
1	Ouabain (G Strophanthin)IBA 01/2016
1	Cardiac GlycosidesIBA 01/2016
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2016
1	alpha-SynucleinIBA 12/2015
1	GlycosaminoglycansIBA 11/2014
1	CollagenIBA 09/2014
1	LectinsIBA 09/2014
1	Complement Inactivating AgentsIBA 09/2014
1	Heparin (Liquaemin)FDA LinkGeneric 03/2014
1	EnzymesIBA 01/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	Histidine (L-Histidine)FDA Link 05/2013
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2012
1	3' Untranslated Regions (3' UTR)IBA 10/2012
1	ELAV-Like Protein 1IBA 10/2012
1	ArginaseIBA 10/2012
1	Interferon LambdaIBA 04/2010
1	Interferon Receptors (Interferon Receptor)IBA 04/2010
1	STAT1 Transcription FactorIBA 10/2009

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2011
1	Immunomodulation 01/2020